Increasing intervention of the government with regards to funding for research and development activities coupled with rising R&D activities in proteomics and genomics and advancement in technology is expected to drive the qPCR assay market during the forecast period. Growing approaches for new diagnostic tools and techniques, evaluation of benefits to patient outcome and developing genome profiling techniques are the drivers expected to fuel the qPCR assay market in the recent years. qPCR allows quantification and amplification of a real time targeted DNA molecule. It requires small sample and provides with higher sensitivity, efficiency and accuracy than the conventional PCR.
On the basis of product, the market is segmented into qPCR consumables, qPCR instruments and qPCR services. On the basis of application the qPCR assay market is classified into drug discovery, drug development, diagnosis, research and others. qPCR technology is majorly used in various diagnostic and research applications such as quantification of nucleic acid standards, rare allele detection, viral load quantification, separation and enrichment of mixtures, low-fold copy number discrimination and NGS libraries quantification.
Geographically, cosmetic implant market is studied with respect to four regions as North America, Europe, RoW and Asia Pacific. The increasing requirement of personalized healthcare genetic testing in various disease areas such as cancer and diabetes is expected to fuel the qPCR assay market. The U.S. coding guidelines has assigned codes to reimbursement policies and healthcare services. Increasing prevalence of cardiovascular disorders and genetic disorders coupled with the rising investments in proteomics and genomics is expected to drive the qPCR assay market in the North American region during the forecast period. Asia Pacific market is projected to grow rapidly due to the development of various new technologies by the research institutes of emerging economies such as India, Japan and China.
Some key players in this market are Affymetrix Inc., Cepheid, Qiagen, Abbott Laboratories, Agilent Technologies, Bio-Rad, Beckman Coulter Inc., Becton, Dickinson and Co., Sigma-Aldrich Corp, GE Healthcare, Life Technologies and Roche. Two most commonly used methods for labeling and detecting PCR products are TaqMan Assay or fluorogenic 5’ nuclease chemistry and SYBR Chemistry Green dye chemistry by LifeTechnologies.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."